Coherus BioSciences
Price & Volume
Stats
See moreOpen | $1.11 |
Previous Close | $1.13 |
Day Range | $1.03-$1.11 |
52W Range | $1.01-$4.36 |
Market Cap | $120.9M |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $308.1M |
Revenue Growth (YoY) | 10.7% |
Gross Profit (12 Mos) | -$58.3M |
Diluted EPS | -$0.38 |
News
See moreYahoo Finance • 9 months ago
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
Yahoo Finance • 9 months ago
Coherus BioSciences Announces New Employment Inducement Grants
Yahoo Finance • 9 months ago
Coherus Announces Updated NCCN Clinical Practice Guidelines Positioning LOQTORZI™ (toripalimab-tpzi) as Preferred Category 1 Regimen for First-Line Treatment of Cancer of the Nasopharynx
Yahoo Finance • 9 months ago
Coherus BioSciences Announces CFO Transition Plans
About
CEO | Mr. Dennis M. Lanfear |
CFO | Mr. Bryan J. McMichael |
Address | 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 246 |
